• Epinephrine and morphine added to FDA’s COVID-19 compounding lists

    Two more injectable medications have been added to the US Food and Drug Administration’s (FDA) guidances on drugs that can be compounded by registered outsourcing facilities and some smaller compounders if they are used for patients hospitalized with the novel coronavirus COVID-19.   The addition of epinephrine and morphine sulfate to the guidances brings the total number of drugs listed to 15. Most of the medications are anesthetics or analgesics that support mechanic...
  • FDA Calls out Pharma Company for Repeated 'Violative' Marketing Practices

    The US Food and Drug Administration (FDA) released a warning letter sent to Octapharma USA, Inc on 10 April 2012, in which the agency scolds the company for numerous marketing violations. FDA's Advertising and Promotional Labeling Branch (APLB), located within the Center for Biologics Research and Evaluation, reviewed some of Octapharma's advertisements within two publications released in December 2011. FDA rapped Octapharma for "false and misleading" advertisements aft...